Spot and Tubular data show prescription immunology brands continued to dominate TV, while seasonal OTC brands found scale on ...
After losing the top spot in March to Johnson & Johnson’s immunology drug Tremfya, AbbVie’s rival med Skyrizi is back as the drug with the highest level of ad spending. | After losing the top spot in ...
Skyrizi, Rinvoq and Tremfya claimed the top three spots in the linear TV rankings in March. Seasonal OTC brands like Vicks and Afrin stayed highly visible, following the cold and flu wave. News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results